StockData
Cocrystal Pharma, Inc. logo

Cocrystal Pharma, Inc. (COCP) income statement

COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.95−0.02 (-2.05%)

Close on Nov 20, 2026Market cap $18.30MP/E –Yield –

See a number that looks wrong?